No Recurrence of VTE 1 Year after COVID-19-Associated VTE Event
A study was conducted to determine outcomes in hospitalized patients with COVID-19 and VTE, during anticoagulation therapy and at 1-year follow-up.
Thrombosis
Anticoagulation Therapy Following Intracranial Hemorrhage in Atrial Fibrillation
Researchers examined the effect of anticoagulation therapy in patients with atrial fibrillation on risk for severe thrombotic events and severe hemorrhage events.
Thromboprophylaxis Reduces Risk of VTE for Patients With Sickle Cell Disease and a Central Venous Access Device
Researchers sought to determine whether thromboprophylaxis would reduce venous thromboembolism risk in patients with SCD and a central venous access device.
Thrombolysis vs Surgery for Treatment of Obstructive Prosthetic Valve Thrombosis
Investigators compared outcomes of thrombolytic therapy and surgery as first-line treatment for patients with obstructive prosthetic valve thrombosis.
CYP2C19 Loss-Of-Function Carriers Treated with Clopidogrel Following PCI
A study was conducted to determine clinical outcomes for patients who received CYP2C19-guided antiplatelet therapy after percutaneous coronary intervention.
Postprocedural Anticoagulation Decreases Mortality Rates After Primary PCI for STEMI
A study assessed the association between postprocedural anticoagulation therapy and multiple clinical outcomes in patients with STEMI.
![AF is a complex condition associated with mechanical, electrical, and structural abnormalities of the atria; thus, many factors can predispose to its development.[6] It is most common in patients aged ≥65 years, affecting 9% of this population.[1] It is also more common in women, those of European descent, those with predisposing comorbidities and lifestyle factors, and after surgery.[1] Comorbidities that increase the risk of AF include obesity, cardiovascular conditions (eg, hypertension, coronary artery disease, structural heart disease), and other chronic conditions (eg, hyperthyroidism, asthma). Heavy alcohol use is known to increase risk of developing AF, but a recently published study indicates that regular consumption of even small amounts of alcohol can lead to atrial enlargement and subsequent AF.[7] In addition, several cases of AF after episodes of heavy binge drinking have been reported in people who normally drink little or no alcohol and have no underlying cardiovascular comorbidities.[8]](https://www.thecardiologyadvisor.com/wp-content/uploads/sites/17/2019/01/slideshowsizefeaturehyperten_1061303-544x306.jpg)
USPSTF Releases Update on Harms vs Benefits of Atrial Fibrillation Screening
The USPSTF evaluated the harms and benefits of screening for atrial fibrillation in adults without history of stroke.
Genotype-Guided Warfarin Therapy Significantly Improves Efficacy Outcomes
A study was conducted to determine the efficacy and safety of genotype-guided dosing strategies for patients receiving warfarin.
Updated CHEST Guidelines on Antithrombotic Therapy in Venous Thromboembolism
The updated CHEST guideline on antithrombotic therapy for VTE includes 4 new PICO questions as well as updated recommendations based on newer evidence.
Noncontrast CT for Mechanical Thrombectomy in Extended Time Window: The Outcomes
In a multinational cohort study, researchers compared the clinical outcomes of patients selected for mechanical thrombectomy by noncontrast CT vs those selected by CTP or MRI in the extended time window.
- Loading...
Loading...
Loading... 
Loading...